Nexaph peptides represent a promising therapeutic strategy targeting disease progression. These modified entities leverage the distinct properties of short peptide sequences to modulate cellular processes involved in reaction, scarring, and tumor proliferation. Research indicate their possibility for addressing a range of persistent diseases, offer